Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03118557
Does a twice weekly, 12-week Pilates pelvic floor strengthening program improve short- and long-term measures of stress urinary incontinence symptoms in women ages 45-70 years of age?
Looking for future studies?
Notify Me45 year–70 year
Female
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pilates pelvic floor strengthening.
Time frame: Baseline, 12 weeks
The ICIQ-UI Short Form consists of 3 questions. The ICIQ score is a sum of the responses to the 3 questions with a total possible range of 0 (none) to 21 (all the time/a great deal).
Time frame: Baseline, 12 weeks
The MESA Urinary Incontinence Questionnaire consists of 3 sections: General questions (unscored), Urge Incontinence (6 questions), and Stress Incontinence (9 questions). The scored questions can range from 0 (never) to 3 (often). The score for the Urge Incontinence is the sum of the responses/18, and the score for the Stress Incontinence section is the sum of the responses/27.
Time frame: Baseline, 12 weeks
The LASA questionnaire consists of 6 questions, each ranging from 0 (as bad as it can be) to 10 (as good as it can be). Therefore, the total possible scores would range from 0 (as bad as it can be) to 60 (as good as it can be).
Mayo Clinic
Other
HLP-16-003H: Does a Twice Weekly, 12-week Pilates Pelvic Floor Strengthening Program Improve Short- and Long-term Measures of Stress Urinary Incontinence Symptoms in Women Ages 45-70 Years of Age.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07668128
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Taipei City, Banqiao Dist, Taiwan
View Trial DetailsNCT03913845
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bethel Park, Pennsylvania, United States
View Trial DetailsNCT02785016
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Frauenfeld, Thurgau, Switzerland
View Trial DetailsNCT07095283
Behavior, Female Urogenital Diseases
Elche, Alicante, Spain
View Trial Details